Republicans in Congress seek to implement trillion-dollar Medicaid reforms through reconciliation, targeting waste, fraud, and abuse while expanding tax cuts and curbing federal spending growth.
CVS Health announces exit from individual ACA plans and expands Wegovy access amid strong Q1 earnings, signaling strategic focus on higher-margin healthcare segments.
House Republican proposals to cut Medicaid funding threaten Washington D.C.'s healthcare system, risking coverage for 40% of residents and essential services. The debate highlights funding structures and potential impacts on hospitals and clinics.
Explore challenges patients face with ACA preventive care coverage where diagnostic lab tests during annual checkups lead to unexpected bills. Understand insurer policies, site-neutral payment reform, and regulatory risks affecting U.S. health insurance and preventive services.
Atrium Health Levine Cancer's Financial Toxicity Tumor Board mitigates financial distress among cancer patients, improving treatment outcomes and reducing insurance claim denials. A five-year study highlights its efficacy and suggests it as a best practice for cancer centers.
AmeriLife enhances its Health Distribution platform through a new partnership with Senior Health Insurance Direct, expanding agent recruitment and training capabilities nationwide.
Politico’s use of sponsored content from health insurance and fossil fuel industries raises ethical questions about transparency and editorial independence, impacting U.S. Medicare Advantage and policy discourse.
Explore how U.S. employers are adopting value-based care models to improve employee health benefits, increase retention, and manage healthcare costs effectively through personalized plans, preventive care, benefits literacy, and price transparency.
Congressional proposals to reduce Medicaid funding by $880 billion may restrict access to vital care for nearly 80 million Americans, including many children and vulnerable groups. Policymakers are also considering work requirements that could further limit coverage.
Recent U.S. health policy debates focus on autism's classification, NIH's new autism registry, data privacy concerns, and implications for insurance and early intervention programs.
